Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04777903
Other study ID # SAHoWMU-CR2021-07-201
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 1, 2016
Est. completion date June 30, 2021

Study information

Verified date February 2021
Source Second Affiliated Hospital of Wenzhou Medical University
Contact Ying Hua
Phone +8613676403165
Email wzfeyhy1015@126.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Prepregnancy body mass index (BMI) and gestational weight gain (GWG) have Significant effects on the risk of pregnancy outcomes such as gestational hypertension disease and gestational diabetes mellitus in singleton pregnancies. This paper is to investigate the relationship between pre-pregnancy body mass index (BMI) and weight gain during pregnancy and pregnancy outcomes in women with twin pregnancy.


Recruitment information / eligibility

Status Recruiting
Enrollment 250
Est. completion date June 30, 2021
Est. primary completion date December 31, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria: - Age 18 ~ 41 years old; - The gestational age of the first diagnosed twin pregnancy is =10weeks; - Double chorionic double amniotic sac pregnancy; Exclusion Criteria: - with heart disease, liver disease, kidney disease, complications (chronic hypertension, hyperthyroidism, diabetes and others ), genetic diseases, psychological and mental diseases; - with history of habitual abortion and cervical insufficiency;

Study Design


Related Conditions & MeSH terms


Intervention

Other:
collect date about all participants
a standardized and structured questionnaire that included information on age, residence, education, pregnancy history, disease history, height, and conception method, after obtaining the consent of all participants.

Locations

Country Name City State
China department of obstetrics of Second Affiliated Hospital of Wenzhou Medical University Wenzhou Zhejiang

Sponsors (1)

Lead Sponsor Collaborator
Second Affiliated Hospital of Wenzhou Medical University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary the incidence of gestational diabetes mellitus, gestational hypertension and small for gestational age pregnant outcome 35 weeks to 40 weeks gestation